Brawn Biotech Ltd — Important, 13-01-2026: Company Update

Brawn Biotech has confirmed its adherence to compliance standards by submitting a certificate from its Registrar and Share Transfer Agent for the quarter ended December 31, 2025. This document validates the proper processing of all share transfer and dematerialization requests, ensuring accurate and efficient management of shareholder records. Such routine compliance underscores the company's commitment to maintaining operational transparency and investor trust in its shareholding processes.